img

Global Artificial Joint Infection Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Artificial Joint Infection Treatment Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Artificial Joint Infection Treatment Market
Global Artificial Joint Infection Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Artificial Joint Infection Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Artificial Joint Infection Treatment key companies include Arrevus, MELINTA THERAPEUTICS, INC., Nabriva Therapeutics plc, Peptilogics, Telephus Medical LLC, TenNor Therapeutics Ltd, Cempra Inc, Motif Bio Plc and Johnson & Johnson Services, etc. Arrevus, MELINTA THERAPEUTICS, INC., Nabriva Therapeutics plc are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Artificial Joint Infection Treatment were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Artificial Joint Infection Treatment market and estimated to attract more attentions from industry insiders and investors.
Artificial Joint Infection Treatment can be divided into Aminoglycosides, Glycopeptides, Rifamycin and Lincosamide, etc. Aminoglycosides is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Artificial Joint Infection Treatment is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Artificial Joint Infection Treatment industry development. In 2022, global % revenue of Artificial Joint Infection Treatment went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Artificial Joint Infection Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Artificial Joint Infection Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Arrevus
MELINTA THERAPEUTICS, INC.
Nabriva Therapeutics plc
Peptilogics
Telephus Medical LLC
TenNor Therapeutics Ltd
Cempra Inc
Motif Bio Plc
Johnson & Johnson Services
Segment by Type
Aminoglycosides
Glycopeptides
Rifamycin
Lincosamide
Penicillin
Others

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Artificial Joint Infection Treatment introduction, etc. Artificial Joint Infection Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Artificial Joint Infection Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Joint Infection Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Aminoglycosides
1.2.3 Glycopeptides
1.2.4 Rifamycin
1.2.5 Lincosamide
1.2.6 Penicillin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Artificial Joint Infection Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Joint Infection Treatment Market Perspective (2018-2029)
2.2 Global Artificial Joint Infection Treatment Growth Trends by Region
2.2.1 Artificial Joint Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Joint Infection Treatment Historic Market Size by Region (2018-2024)
2.2.3 Artificial Joint Infection Treatment Forecasted Market Size by Region (2024-2029)
2.3 Artificial Joint Infection Treatment Market Dynamics
2.3.1 Artificial Joint Infection Treatment Industry Trends
2.3.2 Artificial Joint Infection Treatment Market Drivers
2.3.3 Artificial Joint Infection Treatment Market Challenges
2.3.4 Artificial Joint Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Joint Infection Treatment by Players
3.1.1 Global Artificial Joint Infection Treatment Revenue by Players (2018-2024)
3.1.2 Global Artificial Joint Infection Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Artificial Joint Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Joint Infection Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Artificial Joint Infection Treatment Market Concentration Ratio
3.4.1 Global Artificial Joint Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Joint Infection Treatment Revenue in 2022
3.5 Global Key Players of Artificial Joint Infection Treatment Head office and Area Served
3.6 Global Key Players of Artificial Joint Infection Treatment, Product and Application
3.7 Global Key Players of Artificial Joint Infection Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Joint Infection Treatment Breakdown Data by Type
4.1 Global Artificial Joint Infection Treatment Historic Market Size by Type (2018-2024)
4.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029)
5 Artificial Joint Infection Treatment Breakdown Data by Application
5.1 Global Artificial Joint Infection Treatment Historic Market Size by Application (2018-2024)
5.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Joint Infection Treatment Market Size (2018-2029)
6.2 North America Artificial Joint Infection Treatment Market Size by Type
6.2.1 North America Artificial Joint Infection Treatment Market Size by Type (2018-2024)
6.2.2 North America Artificial Joint Infection Treatment Market Size by Type (2024-2029)
6.2.3 North America Artificial Joint Infection Treatment Market Share by Type (2018-2029)
6.3 North America Artificial Joint Infection Treatment Market Size by Application
6.3.1 North America Artificial Joint Infection Treatment Market Size by Application (2018-2024)
6.3.2 North America Artificial Joint Infection Treatment Market Size by Application (2024-2029)
6.3.3 North America Artificial Joint Infection Treatment Market Share by Application (2018-2029)
6.4 North America Artificial Joint Infection Treatment Market Size by Country
6.4.1 North America Artificial Joint Infection Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Joint Infection Treatment Market Size by Country (2018-2024)
6.4.3 North America Artificial Joint Infection Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Artificial Joint Infection Treatment Market Size (2018-2029)
7.2 Europe Artificial Joint Infection Treatment Market Size by Type
7.2.1 Europe Artificial Joint Infection Treatment Market Size by Type (2018-2024)
7.2.2 Europe Artificial Joint Infection Treatment Market Size by Type (2024-2029)
7.2.3 Europe Artificial Joint Infection Treatment Market Share by Type (2018-2029)
7.3 Europe Artificial Joint Infection Treatment Market Size by Application
7.3.1 Europe Artificial Joint Infection Treatment Market Size by Application (2018-2024)
7.3.2 Europe Artificial Joint Infection Treatment Market Size by Application (2024-2029)
7.3.3 Europe Artificial Joint Infection Treatment Market Share by Application (2018-2029)
7.4 Europe Artificial Joint Infection Treatment Market Size by Country
7.4.1 Europe Artificial Joint Infection Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Joint Infection Treatment Market Size by Country (2018-2024)
7.4.3 Europe Artificial Joint Infection Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Joint Infection Treatment Market Size (2018-2029)
8.2 China Artificial Joint Infection Treatment Market Size by Type
8.2.1 China Artificial Joint Infection Treatment Market Size by Type (2018-2024)
8.2.2 China Artificial Joint Infection Treatment Market Size by Type (2024-2029)
8.2.3 China Artificial Joint Infection Treatment Market Share by Type (2018-2029)
8.3 China Artificial Joint Infection Treatment Market Size by Application
8.3.1 China Artificial Joint Infection Treatment Market Size by Application (2018-2024)
8.3.2 China Artificial Joint Infection Treatment Market Size by Application (2024-2029)
8.3.3 China Artificial Joint Infection Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artificial Joint Infection Treatment Market Size (2018-2029)
9.2 Asia Artificial Joint Infection Treatment Market Size by Type
9.2.1 Asia Artificial Joint Infection Treatment Market Size by Type (2018-2024)
9.2.2 Asia Artificial Joint Infection Treatment Market Size by Type (2024-2029)
9.2.3 Asia Artificial Joint Infection Treatment Market Share by Type (2018-2029)
9.3 Asia Artificial Joint Infection Treatment Market Size by Application
9.3.1 Asia Artificial Joint Infection Treatment Market Size by Application (2018-2024)
9.3.2 Asia Artificial Joint Infection Treatment Market Size by Application (2024-2029)
9.3.3 Asia Artificial Joint Infection Treatment Market Share by Application (2018-2029)
9.4 Asia Artificial Joint Infection Treatment Market Size by Region
9.4.1 Asia Artificial Joint Infection Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Joint Infection Treatment Market Size by Region (2018-2024)
9.4.3 Asia Artificial Joint Infection Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arrevus
11.1.1 Arrevus Company Details
11.1.2 Arrevus Business Overview
11.1.3 Arrevus Artificial Joint Infection Treatment Introduction
11.1.4 Arrevus Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.1.5 Arrevus Recent Developments
11.2 MELINTA THERAPEUTICS, INC.
11.2.1 MELINTA THERAPEUTICS, INC. Company Details
11.2.2 MELINTA THERAPEUTICS, INC. Business Overview
11.2.3 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Introduction
11.2.4 MELINTA THERAPEUTICS, INC. Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.2.5 MELINTA THERAPEUTICS, INC. Recent Developments
11.3 Nabriva Therapeutics plc
11.3.1 Nabriva Therapeutics plc Company Details
11.3.2 Nabriva Therapeutics plc Business Overview
11.3.3 Nabriva Therapeutics plc Artificial Joint Infection Treatment Introduction
11.3.4 Nabriva Therapeutics plc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.3.5 Nabriva Therapeutics plc Recent Developments
11.4 Peptilogics
11.4.1 Peptilogics Company Details
11.4.2 Peptilogics Business Overview
11.4.3 Peptilogics Artificial Joint Infection Treatment Introduction
11.4.4 Peptilogics Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.4.5 Peptilogics Recent Developments
11.5 Telephus Medical LLC
11.5.1 Telephus Medical LLC Company Details
11.5.2 Telephus Medical LLC Business Overview
11.5.3 Telephus Medical LLC Artificial Joint Infection Treatment Introduction
11.5.4 Telephus Medical LLC Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.5.5 Telephus Medical LLC Recent Developments
11.6 TenNor Therapeutics Ltd
11.6.1 TenNor Therapeutics Ltd Company Details
11.6.2 TenNor Therapeutics Ltd Business Overview
11.6.3 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Introduction
11.6.4 TenNor Therapeutics Ltd Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.6.5 TenNor Therapeutics Ltd Recent Developments
11.7 Cempra Inc
11.7.1 Cempra Inc Company Details
11.7.2 Cempra Inc Business Overview
11.7.3 Cempra Inc Artificial Joint Infection Treatment Introduction
11.7.4 Cempra Inc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.7.5 Cempra Inc Recent Developments
11.8 Motif Bio Plc
11.8.1 Motif Bio Plc Company Details
11.8.2 Motif Bio Plc Business Overview
11.8.3 Motif Bio Plc Artificial Joint Infection Treatment Introduction
11.8.4 Motif Bio Plc Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.8.5 Motif Bio Plc Recent Developments
11.9 Johnson & Johnson Services
11.9.1 Johnson & Johnson Services Company Details
11.9.2 Johnson & Johnson Services Business Overview
11.9.3 Johnson & Johnson Services Artificial Joint Infection Treatment Introduction
11.9.4 Johnson & Johnson Services Revenue in Artificial Joint Infection Treatment Business (2018-2024)
11.9.5 Johnson & Johnson Services Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Artificial Joint Infection Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Aminoglycosides
Table 3. Key Players of Glycopeptides
Table 4. Key Players of Rifamycin
Table 5. Key Players of Lincosamide
Table 6. Key Players of Penicillin
Table 7. Key Players of Others
Table 8. Global Artificial Joint Infection Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 9. Global Artificial Joint Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Artificial Joint Infection Treatment Market Share by Region (2018-2024)
Table 12. Global Artificial Joint Infection Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Artificial Joint Infection Treatment Market Share by Region (2024-2029)
Table 14. Artificial Joint Infection Treatment Market Trends
Table 15. Artificial Joint Infection Treatment Market Drivers
Table 16. Artificial Joint Infection Treatment Market Challenges
Table 17. Artificial Joint Infection Treatment Market Restraints
Table 18. Global Artificial Joint Infection Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Artificial Joint Infection Treatment Revenue Share by Players (2018-2024)
Table 20. Global Top Artificial Joint Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
Table 21. Global Artificial Joint Infection Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 22. Global 5 Largest Players Market Share by Artificial Joint Infection Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 23. Global Key Players of Artificial Joint Infection Treatment, Headquarters and Area Served
Table 24. Global Key Players of Artificial Joint Infection Treatment, Product and Application
Table 25. Global Key Players of Artificial Joint Infection Treatment, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2024)
Table 29. Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2024-2029)
Table 31. Global Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Artificial Joint Infection Treatment Revenue Share by Application (2018-2024)
Table 33. Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Artificial Joint Infection Treatment Revenue Share by Application (2024-2029)
Table 35. North America Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 36. North America Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 37. North America Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 38. North America Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 39. North America Artificial Joint Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. North America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 41. North America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Europe Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 43. Europe Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 44. Europe Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 45. Europe Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 46. Europe Artificial Joint Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Europe Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 48. Europe Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 49. China Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 50. China Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. China Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 52. China Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 54. Asia Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 55. Asia Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 56. Asia Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 57. Asia Artificial Joint Infection Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 58. Asia Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 59. Asia Artificial Joint Infection Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 65. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 67. Arrevus Company Details
Table 68. Arrevus Business Overview
Table 69. Arrevus Artificial Joint Infection Treatment Product
Table 70. Arrevus Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 71. Arrevus Recent Developments
Table 72. MELINTA THERAPEUTICS, INC. Company Details
Table 73. MELINTA THERAPEUTICS, INC. Business Overview
Table 74. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Product
Table 75. MELINTA THERAPEUTICS, INC. Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 76. MELINTA THERAPEUTICS, INC. Recent Developments
Table 77. Nabriva Therapeutics plc Company Details
Table 78. Nabriva Therapeutics plc Business Overview
Table 79. Nabriva Therapeutics plc Artificial Joint Infection Treatment Product
Table 80. Nabriva Therapeutics plc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 81. Nabriva Therapeutics plc Recent Developments
Table 82. Peptilogics Company Details
Table 83. Peptilogics Business Overview
Table 84. Peptilogics Artificial Joint Infection Treatment Product
Table 85. Peptilogics Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 86. Peptilogics Recent Developments
Table 87. Telephus Medical LLC Company Details
Table 88. Telephus Medical LLC Business Overview
Table 89. Telephus Medical LLC Artificial Joint Infection Treatment Product
Table 90. Telephus Medical LLC Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 91. Telephus Medical LLC Recent Developments
Table 92. TenNor Therapeutics Ltd Company Details
Table 93. TenNor Therapeutics Ltd Business Overview
Table 94. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Product
Table 95. TenNor Therapeutics Ltd Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 96. TenNor Therapeutics Ltd Recent Developments
Table 97. Cempra Inc Company Details
Table 98. Cempra Inc Business Overview
Table 99. Cempra Inc Artificial Joint Infection Treatment Product
Table 100. Cempra Inc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 101. Cempra Inc Recent Developments
Table 102. Motif Bio Plc Company Details
Table 103. Motif Bio Plc Business Overview
Table 104. Motif Bio Plc Artificial Joint Infection Treatment Product
Table 105. Motif Bio Plc Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 106. Motif Bio Plc Recent Developments
Table 107. Johnson & Johnson Services Company Details
Table 108. Johnson & Johnson Services Business Overview
Table 109. Johnson & Johnson Services Artificial Joint Infection Treatment Product
Table 110. Johnson & Johnson Services Revenue in Artificial Joint Infection Treatment Business (2018-2024) & (US$ Million)
Table 111. Johnson & Johnson Services Recent Developments
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Joint Infection Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Artificial Joint Infection Treatment Market Share by Type: 2022 VS 2029
Figure 3. Aminoglycosides Features
Figure 4. Glycopeptides Features
Figure 5. Rifamycin Features
Figure 6. Lincosamide Features
Figure 7. Penicillin Features
Figure 8. Others Features
Figure 9. Global Artificial Joint Infection Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Artificial Joint Infection Treatment Market Share by Application: 2022 VS 2029
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Artificial Joint Infection Treatment Report Years Considered
Figure 15. Global Artificial Joint Infection Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Artificial Joint Infection Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Artificial Joint Infection Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Artificial Joint Infection Treatment Market Share by Players in 2022
Figure 19. Global Top Artificial Joint Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Artificial Joint Infection Treatment Revenue in 2022
Figure 21. North America Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Artificial Joint Infection Treatment Market Share by Type (2018-2029)
Figure 23. North America Artificial Joint Infection Treatment Market Share by Application (2018-2029)
Figure 24. North America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 25. United States Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Artificial Joint Infection Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Artificial Joint Infection Treatment Market Share by Type (2018-2029)
Figure 29. Europe Artificial Joint Infection Treatment Market Share by Application (2018-2029)
Figure 30. Europe Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 31. Germany Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Artificial Joint Infection Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Artificial Joint Infection Treatment Market Share by Type (2018-2029)
Figure 39. China Artificial Joint Infection Treatment Market Share by Application (2018-2029)
Figure 40. Asia Artificial Joint Infection Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Artificial Joint Infection Treatment Market Share by Type (2018-2029)
Figure 42. Asia Artificial Joint Infection Treatment Market Share by Application (2018-2029)
Figure 43. Asia Artificial Joint Infection Treatment Market Share by Region (2018-2029)
Figure 44. Japan Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 54. Brazil Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Artificial Joint Infection Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Arrevus Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 61. MELINTA THERAPEUTICS, INC. Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 62. Nabriva Therapeutics plc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 63. Peptilogics Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 64. Telephus Medical LLC Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 65. TenNor Therapeutics Ltd Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 66. Cempra Inc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 67. Motif Bio Plc Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 68. Johnson & Johnson Services Revenue Growth Rate in Artificial Joint Infection Treatment Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries